Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) Tops Q3 EPS by 7c; Raises Outlook
October 21, 2020 4:17 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.51, $0.07 better than the analyst estimate of $0.44. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.08 billion.
"I am very proud of the way our passionate team is serving patients during this... More
